1 / 28

A Start-up Company’s Perspective on Patent Prosecution

A Start-up Company’s Perspective on Patent Prosecution. Carolina Innovations Seminar January 8, 2009. Overview: A Start-up’s Perspective on Patent Prosecution. Overview of Liquidia’s Technology Intellectual Property Perspective of Liquidia At conception Today

maris
Download Presentation

A Start-up Company’s Perspective on Patent Prosecution

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. A Start-up Company’s Perspective on Patent Prosecution Carolina Innovations Seminar January 8, 2009

  2. Overview: A Start-up’s Perspective on Patent Prosecution • Overview of Liquidia’s Technology • Intellectual Property Perspective of Liquidia • At conception • Today • Start-up Patent Strategy Considerations • Prosecution Activities • Enforcement / Defense Considerations

  3. 2 μm Pattern Replication In Non-wetting Templates (PRINT®) Fluorocur® Mold Master Template or Replicate “High Resolution Soft Lithography: Enabling Materials for Nano-Technologies”; Rolland, J. P.; Hagberg, E. C.; Denison, G. M.; Carter, K. R.; DeSimone, J. M. Angew. Chem. Int. Ed. 2004, 43, 5796-5799 .

  4. PRINT® Film Fabrication

  5. PRINT® Particle Fabrication Apply liquid to be molded Form Fluorocur® mold

  6. Control of Particle Size and Shape at the Nanoscale d = 95 nm, h = 280 nm d = 113 nm, h = 36 nm d = 200 nm, L = 200 nm Worm-like Flexible PRINT™ Particles: 80 nm x 2000 nm

  7. PRINT® Particle Therapeutics 200 nm degradable particles with siRNA 3 μm drug particles for pulmonary delivery 2 μm vaccine particles 80 x 5000 nm particles for enhanced circulation

  8. History of Liquidia – an IP Perspective

  9. Liquidia Today – an IP Perspective Films & Membranes Applications Particle Applications Films & Membranes Particles PRINT® Process Fluorocur® Material Foundation

  10. Liquidia Today – an IP Perspective Fluorocur® Material Foundation Fluoropolymer Compositions of Matter Trademarks Trade Secrets

  11. Liquidia Today – an IP Perspective PRINT® Process Manufacturing tools and techniques Methods of making and using Mold materials Methods of making and using Compositions of Matter Methods of using Trade Secrets

  12. Liquidia Today – an IP Perspective Films & Membranes Micro & Nano-Patterned Films Micro & Nano Arrays Microfluidic Devices Photovoltaic Devices Molds Medical Devices Including: Methods of Making and Using

  13. Liquidia Today – an IP Perspective Particles Micro & Nano-Particles Harvesting, Collecting, & Purifying Particles Molds Including: Methods of Making and Using

  14. Liquidia Today – an IP Perspective Films & Membranes Applications Applications: Optical Films, Nano Wire Grid Polarizer, Liquid Crystal Alignment Layer, Alternative Energy, Photovoltaic Device Patterned Layers, Fuel Cell Membrane, Patterned Membrane Including: Methods of making and using

  15. Liquidia Today – an IP Perspective Particle Applications Applications: Drug Delivery Particles, Inhalation Particles, Protein Particles, Targeted Particles, Specific Particle Compositions, Size and/or Shape Specific Particles Including: Methods of making and using, Treating a patient, Dosages, etc.

  16. Choosing a Law Firm / Representation • Considerations: • Location • Local can visit and become more comfortable and familiar with your technology, know reputation • Experience • Technical alignment • Legal expertise • Cost • Size • Some law firms and/or groups are more tailored to working with small start-ups • Larger firms typically offer more full service • Corporate, licensing, employment…

  17. Initial Patent Filings • Highly Important • Creation of value • Establishes initial footprint of company • Priority date for your technology • Timing • File early • File prior to any disclosure to potential investors, collaborators, and any third-party

  18. Initial Patent Filings: Disclosure

  19. Follow on Filings • Protect ongoing technical developments • Create value • Increase your licensing position • Foresee where customers / competitors are and how your technology may apply in their field • Create layers of IP protection around your core background • Enforceability • Strategize to enforce your follow-on filings rather than most core filings whenever possible • If lose a follow on filing less damaging to the company

  20. Route of Patent Filings • Timing • Provisional application • 12 months • Very low filing fees • No prosecution • Must be converted • Patent Cooperation Treaty (PCT) application • 30 months • Limited prosecution • Relatively low filing fees • U.S. non-provisional application • Prosecution begins as soon as filed • Filing fees can be high

  21. Route of Patent Filings • Timing Example 1: Provisional PCT Non-Provisional Filing Date Issuance 12 mo. 30 mo. Time spent in Provisional and PCT status will delay time before issuance. Example 2: Non-Provisional 36-48 mo. Filing Date Issuance By not entering Provisional or PCT national stage, applications should issue quicker, however, larger fees will be incurred earlier.

  22. Route of Patent Filing • Strategy • Cash is king in a start-up • Filing provisional allows you to push off costs • Provisional applications enable dynamic entrepreneurial environment by quickly and efficiently creating value • Caution – filing excessive cases without considering long term costs • Abandonment of non-provisional cases results in the subject matter in that patent application being dedicated to the public if it’s not covered in another filing • Maintain confidentiality • File provisional application – if not converted to PCT or non-provisional you can retain confidentiality • Potential trap • An incomplete provisional application can not be completed / updated upon conversion to Non-provisional or PCT without risking new-matter rejections / challenges

  23. Budget Sample budget for 1 patent filing Note: Translation fees and Prosecution costs are NOT included

  24. Prosecution Activities • Working with Counsel • In-house counsel v outside counsel

  25. Prosecution Activities: Working with the University • A positive University representative can be your best asset • Different models • UNC: very collaborative with company, helps nurture technology • Other Universities: different / less collaborative models • Control prosecution • University concerned with early stage companies • Gain trust and common goal of commercial development as company matures • Interactions with University’s counsel • Remember they do not represent the company • Direct requests and comments through your University representative

  26. Prosecution Activities • File History Watch • Prosecution History Estoppel • Leading countries • US • Europe • Leading claims • Cover products • Quick issuance • Continue to pursue broader claims: costs, law changes • Estoppel • Information Disclosure Statements • Across family members • Watch examiner cited cases – cross-reference • Policy with scientists: centralize all research materials

  27. Enforcement / Defense • Caution when asserting key background cases • Serious blow to company • Family of patents might fall victim • Layered Portfolio • Build cases beyond core background that are independent of the core background and can be asserted • Costs • Patent litigation is very costly

More Related